This content is from: Canada
Canadian Supreme Court decision on GlaxoSmithKline's transfer pricing
The Canadian Supreme Court (SC) has today delivered its first transfer pricing decision, in a case involving GlaxoSmithKline (GSK).
To access our market-driven intelligence please request a trial here.
Read this article – and more – for a 30 day period.
REQUEST ACCESSAre you already an ITR subscriber? Log in here